CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

[1]  J. Parry,et al.  The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. , 2002, Mutagenesis.

[2]  J. Martens,et al.  NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells. , 2001, Molecular endocrinology.

[3]  S. Narod,et al.  Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. , 2001, Journal of the National Cancer Institute.

[4]  G. Coetzee,et al.  Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. , 2001, Cancer research.

[5]  V. Kosma,et al.  Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  Y. Miyoshi,et al.  Genetic polymorphism in CYP17 and breast cancer risk in Japanese women. , 2000, European journal of cancer.

[7]  G. Giles,et al.  CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. , 2000, Journal of the National Cancer Institute.

[8]  K. Matsuo,et al.  No Association of the 5′Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan , 2000, Japanese journal of cancer research : Gann.

[9]  E. Imyanitov,et al.  CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. , 2000, Cancer letters.

[10]  B. Ponder,et al.  A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk 1 , 2000 .

[11]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. , 1999, Cancer research.

[12]  M. Gentile,et al.  Association between CYP17 gene polymorphism and risk of breast cancer in young women , 1999, International journal of cancer.

[13]  M. Pike,et al.  Cytochrome P450c17α Gene (CYP17) Polymorphism Predicts Use of Hormone Replacement Therapy , 1999 .

[14]  P. Lønning,et al.  CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1. , 1999, Cancer research.

[15]  W. Willett,et al.  The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. , 1999, Cancer research.

[16]  I. Bleiweiss,et al.  CYP17 genotype and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  D. Bell,et al.  Association between CYP17 polymorphisms and the development of breast cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  D. Eckerman.  Human Variability in Response to Chemical Exposures Measures, Modeling, and Risk Assessment , 1998 .

[19]  B. Ponder,et al.  No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. , 1998, British Journal of Cancer.

[20]  M. Pike,et al.  Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. , 1998, Cancer research.

[21]  B. Henderson,et al.  A polymorphism in intron 6 of the CYP17 gene , 1997, Clinical genetics.

[22]  G. Coetzee,et al.  A polymorphism in the CYP17 gene increases the risk of breast cancer. , 1997, Cancer research.

[23]  J. Freudenheim,et al.  Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. , 1996, JAMA.

[24]  J. Freudenheim,et al.  Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. , 1996, Journal of the National Cancer Institute.

[25]  K. Morohashi,et al.  Gene regulation of steroidogenesis , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  J. Little,et al.  Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. , 1994, Human molecular genetics.

[27]  L. Hayman,et al.  Correspondence , 1992, Neuroradiology.

[28]  J. Freudenheim,et al.  Nutritional epidemiology of postmenopausal breast cancer in western New York. , 1991, American journal of epidemiology.